Tensile properties of 3D printed INCONEL 718 cellular specimens

The aim of the presented research by the authors was to compare the behaviour of four types of cellular structures under quasi-static tensile stress, while two samples were formed by mono-structures Gyroid 10 % and Diamond 10 %, and the other two types were bi-structures, which were created by combining two single structures (Gyroid 5 % + Gyroid 5 %) and (Gyroid 5 % + Diamond 5 %). The samples were made of Inconel 718 by Direct Metal Laser Sintering technology on an EOS EOSINT M270 machine, and they were heat treated according to AMS 5664 procedure. Tensile tests were performed on an Instron 8802 servo-hydraulic testing machine with a maximum capacity of 250 kN at ambient temperature. The results showed that the maximum load corresponded to the diamond (D) cellular structure (approximately 48 kN), while the minimum load was observed for the gyroid-gyroid (GG) structure (approximately 32 kN)

Effect of crosshead speed and volume ratio on compressive mechanical properties of mono- and double-gyroid structures made of Inconel 718

The current development of additive technologies brings not only new possibilities but also new challenges. One of them is the use of regular cellular materials in various components and constructions so that they fully utilize the potential of porous structures and their advantages related to weight reduction and material-saving while maintaining the required safety and operational reliability of devices containing such components. It is therefore very important to know the properties of such materials and their behavior under different types of loads. The article deals with the investigation of the mechanical properties of porous structures made by the Direct Metal Laser Sintering (DMLS) of Inconel 718. Two types of basic cell topology, mono-structure Gyroid (G) and double-structure Gyroid + Gyroid (GG), with material volume ratios of 10, 15 and 20 %, were studied within our research to compare their properties under quasi-static compressive loading. The testing procedure was performed at ambient temperature with a servo-hydraulic testing machine at three different crosshead testing speeds. The recorded data were processed, while the stress–strain curves were plotted, and Young’s modulus, the yield strength Re0.2, and the stress at the first peak of the local maximum σLocMax were identified. The results showed the best behavior under compression load among the studied structures displayed by mono-structure Gyroid at 10 %. At the same time, it can be concluded that the wall thickness of the structure plays an important role in the compressive properties but on the other hand, crosshead speed doesn´t influence results significantly.Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky, (APVV-19-0550); Kultúrna a Edukacná Grantová Agentúra MŠVVaŠ SR, KEGA, (005TUKE-4/2021, 032TUKE-4/2022, SK-CN-21-0046)ELKEME S.A [APVV-19-0550, KEGA 005TUKE-4/2021, KEGA 032TUKE-4/2022

Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project

Purpose: To describe the epidemiology of intra-abdominal infection in an international cohort of ICU patients according to a new system that classifies cases according to setting of infection acquisition (community-acquired, early onset hospital-acquired, and late-onset hospital-acquired), anatomical disruption (absent or present with localized or diffuse peritonitis), and severity of disease expression (infection, sepsis, and septic shock). Methods: We performed a multicenter (n = 309), observational, epidemiological study including adult ICU patients diagnosed with intra-abdominal infection. Risk factors for mortality were assessed by logistic regression analysis. Results: The cohort included 2621 patients. Setting of infection acquisition was community-acquired in 31.6%, early onset hospital-acquired in 25%, and late-onset hospital-acquired in 43.4% of patients. Overall prevalence of antimicrobial resistance was 26.3% and difficult-to-treat resistant Gram-negative bacteria 4.3%, with great variation according to geographic region. No difference in prevalence of antimicrobial resistance was observed according to setting of infection acquisition. Overall mortality was 29.1%. Independent risk factors for mortality included late-onset hospital-acquired infection, diffuse peritonitis, sepsis, septic shock, older age, malnutrition, liver failure, congestive heart failure, antimicrobial resistance (either methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, extended-spectrum beta-lactamase-producing Gram-negative bacteria, or carbapenem-resistant Gram-negative bacteria) and source control failure evidenced by either the need for surgical revision or persistent inflammation. Conclusion: This multinational, heterogeneous cohort of ICU patients with intra-abdominal infection revealed that setting of infection acquisition, anatomical disruption, and severity of disease expression are disease-specific phenotypic characteristics associated with outcome, irrespective of the type of infection. Antimicrobial resistance is equally common in community-acquired as in hospital-acquired infection

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

A Short Review on Fracture Mechanisms of Mechanical Components Operated under Industrial Process Conditions: Fractographic Analysis and Selected Prevention Strategies

An insight of the dominant fracture mechanisms occurring in mechanical metallic components during industrial service conditions is offered through this short overview. Emphasis is given on the phenomenological aspects of fracture and their relationships with the emergent fracture mode(s) with respect to the prevailed operating parameters and loading conditions. This presentation is basically fulfilled by embracing and reviewing industrial case histories addressed from a technical expert viewpoint. The referenced case histories reflected mainly the author’s team expertise in failure analysis investigation. As a secondary perspective of the current study, selected failure investigation and prevention methodological approaches are briefly summarized and discussed, aiming to provide a holistic overview of the specific frameworks and systems in place, which could assist the organization of risk minimization and quality enhancement

Machinability of Eco-Friendly Lead-Free Brass Alloys: Cutting-Force and Surface-Roughness Optimization

The machinability in turning mode of three lead-free brass alloys, CuZn42 (CW510L), CuZn38As (CW511L) and CuZn36 (C27450) was evaluated in comparison with a reference free-cutting leaded brass CuZn39Pb3 (CW614N), as far as the quality characteristics, i.e., cutting force and surface roughness, were concerned. A design of experiments (DOE) technique, according to the Taguchi L16 orthogonal array (OA) methodology, as well as analysis of variance (ANOVA) were employed in order to identify the critical-to-machinability parameters and to obtain their optimum values for high-performance machining. The experimental design consisted of four factors (cutting speed, depth of cut, feed rate and alloy) with four levels for each factor using the “smaller-the-better” criterion for quality characteristics’ optimization. The data means and signal-to-noise (S/N) responses indicated that the depth of cut and the feed rate were the most influential factors for the cutting force and surface roughness, respectively. The optimized machining parameters for cutting force (34.59 N) and surface roughness (1.22 μm) minimization were determined. Confirmation experiments (cutting force: 39.37 N and surface roughness: 1.71 μm) seem to show that they are in close agreement to the main conclusions, thereby validating the findings of the statistical evaluation performed